Product Citations: 6

Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity.

In Nature on 1 April 2024 by Ross, J. B., Myers, L. M., et al.

Ageing of the immune system is characterized by decreased lymphopoiesis and adaptive immunity, and increased inflammation and myeloid pathologies1,2. Age-related changes in populations of self-renewing haematopoietic stem cells (HSCs) are thought to underlie these phenomena3. During youth, HSCs with balanced output of lymphoid and myeloid cells (bal-HSCs) predominate over HSCs with myeloid-biased output (my-HSCs), thereby promoting the lymphopoiesis required for initiating adaptive immune responses, while limiting the production of myeloid cells, which can be pro-inflammatory4. Ageing is associated with increased proportions of my-HSCs, resulting in decreased lymphopoiesis and increased myelopoiesis3,5,6. Transfer of bal-HSCs results in abundant lymphoid and myeloid cells, a stable phenotype that is retained after secondary transfer; my-HSCs also retain their patterns of production after secondary transfer5. The origin and potential interconversion of these two subsets is still unclear. If they are separate subsets postnatally, it might be possible to reverse the ageing phenotype by eliminating my-HSCs in aged mice. Here we demonstrate that antibody-mediated depletion of my-HSCs in aged mice restores characteristic features of a more youthful immune system, including increasing common lymphocyte progenitors, naive T cells and B cells, while decreasing age-related markers of immune decline. Depletion of my-HSCs in aged mice improves primary and secondary adaptive immune responses to viral infection. These findings may have relevance to the understanding and intervention of diseases exacerbated or caused by dominance of the haematopoietic system by my-HSCs.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

  • Immunology and Microbiology
  • Stem Cells and Developmental Biology

Segmentation, tracking and cell cycle analysis of live-cell imaging data with Cell-ACDC.

In BMC Biology on 5 August 2022 by Padovani, F., Mairhörmann, B., et al.

High-throughput live-cell imaging is a powerful tool to study dynamic cellular processes in single cells but creates a bottleneck at the stage of data analysis, due to the large amount of data generated and limitations of analytical pipelines. Recent progress on deep learning dramatically improved cell segmentation and tracking. Nevertheless, manual data validation and correction is typically still required and tools spanning the complete range of image analysis are still needed.
We present Cell-ACDC, an open-source user-friendly GUI-based framework written in Python, for segmentation, tracking and cell cycle annotations. We included state-of-the-art deep learning models for single-cell segmentation of mammalian and yeast cells alongside cell tracking methods and an intuitive, semi-automated workflow for cell cycle annotation of single cells. Using Cell-ACDC, we found that mTOR activity in hematopoietic stem cells is largely independent of cell volume. By contrast, smaller cells exhibit higher p38 activity, consistent with a role of p38 in regulation of cell size. Additionally, we show that, in S. cerevisiae, histone Htb1 concentrations decrease with replicative age.
Cell-ACDC provides a framework for the application of state-of-the-art deep learning models to the analysis of live cell imaging data without programming knowledge. Furthermore, it allows for visualization and correction of segmentation and tracking errors as well as annotation of cell cycle stages. We embedded several smart algorithms that make the correction and annotation process fast and intuitive. Finally, the open-source and modularized nature of Cell-ACDC will enable simple and fast integration of new deep learning-based and traditional methods for cell segmentation, tracking, and downstream image analysis. Source code: https://github.com/SchmollerLab/Cell_ACDC.
© 2022. The Author(s).

  • Mus musculus (House mouse)

Cell size is a determinant of stem cell potential during aging.

In Science Advances on 12 November 2021 by Lengefeld, J., Cheng, C. W., et al.

Stem cells are remarkably small. Whether small size is important for stem cell function is unknown. We find that hematopoietic stem cells (HSCs) enlarge under conditions known to decrease stem cell function. This decreased fitness of large HSCs is due to reduced proliferation and was accompanied by altered metabolism. Preventing HSC enlargement or reducing large HSCs in size averts the loss of stem cell potential under conditions causing stem cell exhaustion. Last, we show that murine and human HSCs enlarge during aging. Preventing this age-dependent enlargement improves HSC function. We conclude that small cell size is important for stem cell function in vivo and propose that stem cell enlargement contributes to their functional decline during aging.

  • Mus musculus (House mouse)
  • Stem Cells and Developmental Biology

Cell-ACDC: a user-friendly toolset embedding state-of-the-art neural networks for segmentation, tracking and cell cycle annotations of live-cell imaging data

Preprint on BioRxiv : the Preprint Server for Biology on 30 September 2021 by Padovani, F., Mairhörmann, B., et al.

Live-cell imaging is a powerful tool to study dynamic cellular processes on the level of single cells with quantitative detail. Microfluidics enables parallel high-throughput imaging, creating a downstream bottleneck at the stage of data analysis. Recent progress on deep learning image analysis dramatically improved cell segmentation and tracking. Nevertheless, manual data validation and correction is typically still required and broadly used tools spanning the complete range of live-cell imaging analysis, from cell segmentation to pedigree analysis and signal quantification, are still needed. Here, we present Cell-ACDC, a user-friendly graphical user-interface (GUI)-based framework written in Python, for segmentation, tracking and cell cycle annotation. We included two state-of-the-art and high-accuracy deep learning models for single-cell segmentation of yeast and mammalian cells implemented in the most used deep learning frameworks TensorFlow and PyTorch. Additionally, we developed and implemented a cell tracking method and embedded it into an intuitive, semi-automated workflow for label-free cell cycle annotation of single cells. The open-source and modularized nature of Cell-ACDC will enable simple and fast integration of new deep learning-based and traditional methods for cell segmentation or downstream image analysis. h4>Source code/h4> https://github.com/SchmollerLab/Cell_ACDC

  • Mus musculus (House mouse)

Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

In The Journal of Clinical Investigation on 20 May 2019 by Capitano, M. L., Mor-Vaknin, N., et al.

The nuclear protein DEK is an endogenous DNA-binding chromatin factor regulating hematopoiesis. DEK is one of only 2 known secreted nuclear chromatin factors, but whether and how extracellular DEK regulates hematopoiesis is not known. We demonstrated that extracellular DEK greatly enhanced ex vivo expansion of cytokine-stimulated human and mouse hematopoietic stem cells (HSCs) and regulated HSC and hematopoietic progenitor cell (HPC) numbers in vivo and in vitro as determined both phenotypically (by flow cytometry) and functionally (through transplantation and colony formation assays). Recombinant DEK increased long-term HSC numbers and decreased HPC numbers through a mechanism mediated by the CXC chemokine receptor CXCR2 and heparan sulfate proteoglycans (HSPGs) (as determined utilizing Cxcr2-/- mice, blocking CXCR2 antibodies, and 3 different HSPG inhibitors) that was associated with enhanced phosphorylation of ERK1/2, AKT, and p38 MAPK. To determine whether extracellular DEK required nuclear function to regulate hematopoiesis, we utilized 2 mutant forms of DEK: one that lacked its nuclear translocation signal and one that lacked DNA-binding ability. Both altered HSC and HPC numbers in vivo or in vitro, suggesting the nuclear function of DEK is not required. Thus, DEK acts as a hematopoietic cytokine, with the potential for clinical applicability.

View this product on CiteAb